Introduction
Attention-deficit/hyperactivity disorder (ADHD), a disorder that is characterized by symptoms of inattention, impulsivity and/or hyperactivity, is one of the most commonly diagnosed paediatric neuropsychiatric disorders affecting an estimated 3 to 6% of children (1) . An important component of various theories concerning ADHD has been the role of the catecholamines, norepinephrine (NE) and especially dopamine (DA). It has been suggested that ADHD is a consequence of reduced DA activity due to either increased DA synaptic reuptake by or reduced post synaptic sensitivity at fronto-straito-cerebellar networks (2, 3) .
Methylphenidate (MPH) is one of the most commonly prescribed stimulants for the management of ADHD symptoms and acts to increase DA and NE availability by inhibiting reuptake of these catecholamines (4) . While MPH and other stimulants are broadly effective in the management of ADHD symptoms it is estimated that some 25% of stimulant medicated ADHD patients show little or no symptomatic improvement (5) . The ability to identify ADHD patients likely to respond favourably to stimulant medication prospectively is thus important on two grounds. Firstly, if stimulant medication non-responders can be identified, then ineffective medication and related side effects can be avoided. In addition, an understanding of the factors contributing to stimulant medication response would shed additional light on the neurobiological basis of ADHD.
While the cognitive enhancing effect of MPH has generally been considered a consequence of DA related increases in prefrontal activity (6,7) more recently, another perspective on the brain function abnormalities underlying ADHD and the role of stimulants in symptom management has emerged. This perspective views ADHD as a disorder of functional connectivity rather than an abnormality restricted to specific cortical regions (8) . The main M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 development making this reappraisal possible was the recognition of a specific cortical network known as the 'default mode network' (DMN) (9) . The DMN is most active when awake subjects are engaged in stimulus independent cognition such as 'day dreaming' and exhibits reduced activity when task-positive networks become active during a cognitive task (9, 10) .
A reduced negative correlation between the DMN and task active networks has been reported in ADHD suggesting that the inattentiveness observed in this condition is a consequence of inadequate suppression of the DMN and increased intrusion of thoughts unrelated to the task (11, 12) . A number of authors go so far as to suggest that ADHD could be considered a 'default network disorder' (13, 14, 15, 16, 17) . The suggested role of the DMN in ADHD symptomatology is also consistent with findings concerning the effects of stimulant medication on DMN activity. While undertaking a cognitive task, ADHD subjects showed greater suppression of the DMN while on stimulant medication compared to the off medication state (18, 19, 20) .
Given the centrality of the role of DA in theories of ADHD, a number of studies have examined the relationship between the acute effects of DA on brain function in ADHD and the long-term clinical response to stimulant medication. Bush (21) examined the effect of MPH in a group of adults diagnosed with ADHD and reported that 6-week clinical improvements were associated with increased activity in task positive networks and greater inhibition of the DMN. Analogous findings were reported by Schulz (22) noting that the major MPH related changes in brain activity associated with ADHD symptom improvements over a 6 -8 week period were reductions at bilateral primary motor cortex, left supplementary motor cortex and the bilateral posterior cingulate cortex. While the authors attribute the reductions in motor cortex activity to the improvements in impulse control, the posterior cingulate reductions were interpreted as reflecting improved suppression of the M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 DMN. However, while the relationship between MPH and the resultant changes in brain activity in ADHD appears robust, the relationship between changes in brain activity and improvements in ADHD symptoms is not always apparent (23) .
We have previously used a steady state visually evoked potential (SSVEP) based methodology to examine cognitive task related changes in brain electrical activity in ADHD (24) as well as task related changes in brain functional connectivity in ADHD (25) . In an earlier study (26) , we examined FC changes in response to an MPH dose in a stimulant drug naïve group of boys newly diagnosed with ADHD while they performed the A-X version of the continuous performance task. We found that MPH robustly reduced the task related transient FC increase observed in the ADHD group. Furthermore, we observed a significant positive correlation between MPH induced changes in reaction times (RT) during the CPT A-X task and the MPH induced changes in FC so that larger RT reductions were associated with larger FC reductions. Given that RT deficits are one of the most common observations in ADHD (27) , we hypothesized a relationship between the initial changes in FC observed as a result of a single MPH dose and the change in clinical symptom score observed over a longer and more clinically relevant interval. In the current study, we specifically hypothesize that the 3-month improvement in ADHD symptom scores will be associated with the initial FC reduction observed following the first administration of MPH to the group of boys newly diagnosed with ADHD.
Methods and Materials

Participants
The participants comprised 40 right handed, stimulant drug naïve males (mean age 121 months (SD=21 months), mean IQ 101.3 (SD=14.4) newly clinically diagnosed with ADHD according to DSM-IV criteria (28) . All participants were prescribed MPH as the sole 
Procedures
Participants first performed a low-demand reference task followed by the CPT A-X task. Both the reference and CPT A-X tasks were undertaken twice, firstly immediately before and then 90 minutes after the participants were administered their first methylphenidate (MPH) dose set at 0.3mg per kg of participant weight.
In the reference task, participants viewed a repeated presentation of the numbers 1, 2, 3, 4 and 5 and were required to press a micro-switch on the appearance of the 5. In the CPT A-X task participants were required to respond on the unpredictable appearance of an X that had been preceded by an A. In all tasks, the numbers and letters remained on the screen for 2.0 seconds and were followed by a blank screen for 1.5 seconds. The ratio of targets to nontargets was 1:4 and the task duration was 280 seconds. For all tasks, a correct response to a target was defined as one that occurred no less than 100 milliseconds and no more than 1.5 seconds after the appearance of the target. Any responses outside the "correct" time intervals
were defined as errors of commission, or false alarms, while failure to respond in the correct interval was defined as an error of omission.
The cognitive tasks were presented on a computer monitor. Each letter subtended a horizontal and vertical angle of approximately 1.0° when viewed by subjects from a fixed distance of 1.3 m. The stimulus used to evoke the SSVEP was a spatially diffuse 13-Hz sinusoidal flicker subtending a horizontal angle of 160° and a vertical angle of 90°, which was superimposed on the visual fields. This flicker was present throughout the task and special goggles enabled subjects to simultaneously view the cognitive task and the sinusoidal flicker.
SSVEP Recording/processing
The EEG was recorded from 64 scalp sites that included all international 10-20 positions, with additional sites located midway between 10-20 locations previously described (25, 29) . The event related potential elicited by the 13Hz visual flicker is termed the steady state visually evoked potential (SSVEP) and is determined from the EEG Fourier coefficients evaluated over 10 stimulus cycles at the stimulus frequency of 13 Hz, thus yielding a temporal resolution of 0.77 seconds (25) .
Functional Connectivity and SSVEP Event-Related Partial Coherence
Brain functional connectivity was measured using an event related potential methodology termed SSVEP Event Related Partial Coherence (SSVEP-ERPC). We have previously used the SSVEP-ERPC to examine changes in brain FC associated with cognitive tasks (30) and more recently comparing an ADHD and typically developing group while performing the continuous performance task (25) . For more details on the SSVEP-ERPC methodology and statistical considerations, the reader is referred to reference (25) 
For each subject, the SSVEP-ERPC was calculated for all 2016 distinct pairs of electrodes averaged across all correct responses in the reference and CPT A-X tasks before and after MPH administration. Electrode pairs with high partial coherence reflect a stable synchronization or phase difference of the SSVEP between electrode pairs across trials and is thought to reflect functional connectivity between the relevant regions and we will use the terms 'SSVEP-ERPC' and 'functional connectivity' (FC) interchangeably. Details of the SSVEP-ERPC methodology have been previously described (25, 29, 30) . 
Results
Behavioural results
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Pre and post medication mean reaction times (RT) (pre 570 msec SD=140msec, post 571msec SD=142msec) did not differ significantly. However, pooling the MPH mediated RT changes obscures individual MPH mediated RT changes. We have previously reported that MPH mediated changes in RT were correlated with the MPH mediated changes in FC such that larger RT reductions are associated with larger FC reductions. Readers are referred to our previous paper for a more detailed discussion on MPH mediated RT changes in the CPT A-X task (24) . While pre and post medication mean number of errors of omission did not differ significantly (pre errors of omission 1.30 (SD=1.9), post errors of omission 1.33 (SD=1.7)), there was a non-significant tendency for a post medication reduction in errors of commission (pre errors of commission 2.10 (SD=2.6), post errors of commission 1.73 (SD=1.9)).
Symptom Scores
The initial and 3-month parent symptom score are listed in Table 1 and while both I-SIS and H-SIS improved over the 3-month period, these changes were not significantly correlated at the individual level (r=0.287, dF=38, p=0.07). Table 1 At the suggestion of a reviewer, the Supplemental material provides an analysis of the findings based on the difference in symptom score rather than the proportional difference used in the current paper.
Discussion
To the best of our knowledge, this is the first study reporting a relationship between first dose MPH induced changes on brain functional connectivity and long-term response to stimulant medication in ADHD symptoms. It is notable that both inattention and hyperactivity symptoms exhibited improvements after 3 months on MPH and that both of these improvements were associated with initial MPH induced FC reductions. In broad terms, these findings are consistent with the notion that MPH may achieve its therapeutic impact by increasing DA and NE levels which in turn suppress brain functional connectivity networks interfering with task performance, such as but not limited to, the DMN (31).
In the following sections of the discussion, we consider the relationship between the initial MPH induced changes in FC and each of the symptoms, hyperactivity and inattention separately. We base this on the fact that the 3-month MPH induced changes in hyperactivity and inattention symptom scores are not significantly correlated as well as the fact that the timing and topography of ∆FC correlated with long-term hyperactivity symptom improvements is different to the ∆FC correlated with the inattention symptom improvements.
Brain Functional Connectivity correlates of Hyperactivity symptom improvements
Of the two points in time during the CPT A-X trails, where ∆FC was correlated with increased H-SIS, the first of the correlated FC changes was located at frontal/prefrontal sites and occurred immediately after the appearance of the warning 'A' (Fig 1A) . We suggest this (Fig 1B) . The timing of this second peak of correlation suggests that it may represent FC changes associated with the termination of the motor response.
To the extent that our FC measures may give some indication of regional brain activity, our findings are consistent with a number of studies reporting increased regional brain activity at motor execution and planning areas in ADHD (13) . The findings are also consistent with Trans-cranial Magnetic stimulation studies of ADHD that indicate reduced GABA mediated synaptic inhibition in the motor cortex (31) . However, to interpret our hyperactivity findings in the context of ADHD as a disorder of functional connectivity, we take the opportunity to draw on fMRI findings concerning the relationship between impulsivity and brain functional connectivity. Some of these studies of indicated that the normal negative correlation between the DMN and regions associated with motor planning and execution are altered in high impulsive individuals. The normal negative correlation is either reduced or replaced with a positive correlation between the DMN and the motor planning and execution regions such as the left and right dorsolateral premotor cortex (PMdr) (32, 33) . In other words, high impulsivity was associated with a positive PMdr-DMN correlation suggesting that impulsivity could arise from the DMN driving motor planning and execution areas. We consider this finding useful as it offers an interpretive framework for understanding ADHD hyperactivity symptomatology in the context of DMN connectivity abnormalities. The role of M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
13 the DMN in ADHD symptomatology is most frequently discussed in the context of attentional deficits where DMN intrusions are thought to contribute to the attentional deficits in ADHD. The above-mentioned studies offer a parsimonious interpretation of why DMN functional abnormalities may contribute to both attention deficits and hyperactivity, and why the frontal-prefrontal FC changes correlated with hyperactivity symptom improvement that we have observed may be driven (directly, or indirectly) by abnormal DMN activity. In other words, our observations of MPH induced reduction in frontal-prefrontal FC being correlated with improved H-SIS is consistent with the possibility that the frontal/prefrontal FC reduction are in part mediated by MPH reduction of DMN activity and hence a reduction of DMN activation of the motor planning and motor execution regions previously described (32, 33) .
Brain Functional Connectivity correlates of Inattention symptom improvements
While both hyperactivity and inattention symptom improvements are associated with reductions in FC during specific intervals in the CPT A-X task, the similarity ends there. Not only did the correlation between ∆FC and I-SIS occur at one point in time but more importantly, it exhibited a different topography in that the ∆FC associated with inattention symptom improvements were restricted to occipito-parietal sites. The fact that the peak correlation between ∆FC and I-SIS occurs only once 1.0 sec after the appearance of the alerting stimulus 'A' suggests that the improvements are associated with enhanced cue processing. Our findings point to occipito-parietal involvement in ADHD inattention symptomatology and that MPH reductions in parieto-occipital FC during the cue 'A' is associated with long-term improvements in inattention symptom score. The fact that inattention symptom improvement is marked by reduced occipito-parietal FC is also consistent with the notion that inattention is associated with an inability to suppress attention to irrelevant stimuli (34) .
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While the occipital cortex is not normally considered relevant to ADHD (13) a number of EEG and fMRI studies have reported occipital abnormalities in ADHD. For example, Vance (35) reported reduced occipito-parietal activity in a cohort of boys diagnosed with ADHD combined subtype while they performed a mental rotation task. Similarly, occipital FC differences between the ADHD inattentive subtype (ADHD-I) and ADHD combined subtype (ADHD-C) were reported in an fMRI study (36) . Our observation of occipito-parietal ∆FC correlated with I-SIS during the 'A' cue is also consistent with the findings of an ADHD CPT A-X event related potential (ERP) study that reported that ADHD -typically developing group differences during the alerting 'A' were restricted to posterior electrodes (37) , findings that were subsequently confirmed (38).
FMRI studies reporting increased occipital activity in ADHD have been interpreted as an indication of ADHD related compensatory activity in a cognitive task (39). While our observation of the relationship between MPH mediated occipito/parietal FC reduction predicting 3-month inattention symptom improvements is consistent with the 'compensatory activity' hypothesis, we suggest our findings also allow an alternative hypothesis. On a more general note, our findings suggest that inattention and hyperactivity symptom improvements may be in part mediated by distinct cortical networks and this is consistent with some reports suggesting that the ADHD inattentive subtype and the ADHD combined subtypes may possibly constitute distinct disorders (41). Hyperactivity symptom improvements may be mediated predominantly by reductions in frontal and motor supplementary cortex networks FC while inattention symptom improvements may be associated with posterior attentional network system FC reductions. While MPH appears to improve both hyperactivity and inattention symptoms, the distinct anterior-posterior distinction in the topography of ∆FC suggests that both dopamine and nor-epinephrine may play distinct roles in symptomatic improvement. Given the predominantly frontal bias of DA projections originating in the ventral tegmental area and the corresponding posterior bias of NE projections originating in the locus-coeruleus our findings are consistent with the possibility that MPH mediated improvements in hyperactivity symptoms are mediated by DA changes while the inattention improvements occur as a result of MPH induced increases in NE (4) . Notwithstanding the differing roles of these catecholamines in mediating inattention and hyperactivity symptomatic improvements, our findings are consistent with the possibility that the DMN is likely to play a role in both sets of symptoms.
Concluding comments
While we believe these findings may be of interest, we suggest that a number of caveats apply. Firstly, no aspect of the diagnosis or treatment of participants was at the discretion of the investigators. As such, we have limited information on the extent to which patients adhered to the prescribed MPH intake level or the changes in MPH dosage M A N U S C R I P T
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recommended by individual clinicians. Secondly, all participants were MPH naïve and it is possible that participants who had been previously prescribed MPH may respond differently.
In addition, there is a need to determine the replicability of our finding in a larger patient group. Furthermore, any larger replication study should make use of both teacher and parent ratings. Finally, in considering a replication study, it is important to note that the findings depend very much on the methodology used to determine FC. Our method using the 13Hz SSVEP to determine FC will be biased to cortical communication components mediated by oscillations around 13Hz. This is important as 'top-down' or 'feedback' cortical communication is thought to be mediated by synchronous oscillations in the 10Hz -20Hz range (26, 42 ) and thus our findings are preferentially sensitive to top-down processes. Table 1 . Parent rated mean Inattention and Hyperactivity symptom scores prior to and three months after starting MPH medication.
Fig 1.
The correlation frequency curve for the number of electrode pairs where MPH induced changes in FC (∆FC) are correlated with hyperactivity symptom improvement score (H-SIS) where |r|>0.403 corresponding to p<0.01. The red trace indicates the number of electrode pairs where ∆FC is positively correlated with H-SIS while the blue trace illustrates the corresponding value where ∆FC is negatively correlated with H-SIS. Overwhelmingly, we see a negative correlation between ∆FC at frontal and prefrontal sites and H-SIS indicating that long-term hyperactivity symptom reductions were associated with an MPH mediated reduction in FC. Permutation tests indicate that the probability of observing the illustrated number of correlations by chance (the null hypothesis) is p<0.01 for the first peak (topography illustrated in Fig 1a) and p<0.01 for the second peak (topography illustrated in Fig 1b) . In analyzing the relationship between the methylphenidate induced short term changes in brain functional connectivity and the 3-month Symptom Improvement Score (SIS), our published paper used a proportional change in 3-month symptom score to define the SIS (see legend for Table S1 below). In the review process, it was pointed out that proportional changes in symptom score are susceptible to 'baseline effects' in that the combination of a small changes in symptom score and a small initial score may result in a large proportional change.
In considering this issue, we re-analyzed the findings where the SIS was defined in terms of the difference in 3-month symptom score rather than the proportional difference. The reanalyzed findings are consistent with those presented in the paper and are presented below for the convenience of the reader.
While we note that such 'baseline effects' in proportional change measures may appear to inflate small differences in symptom score, we believe there are also grounds supporting the use of proportional changes in symptom score. While this will very much depend on the specific symptom score used, for the ones presented here, we believe that proportional changes in symptom score may provide a more faithful reflection of underlying changes in brain function associated with the therapeutic intervention. 
